Polarean Imaging Plc
("Polarean" or the "Company")
Director Dealing
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, announces that it was notified on 10 October 2019 that Dr Jonathan Allis, a Non-Executive Director of the Company, purchased 1,540,000 Ordinary Shares of £0.00037 ("Ordinary Shares") at a price of 13.06 pence per share on 8 October 2019.
Following this transaction, Dr Allis now holds a beneficial interest in 1,540,000 Ordinary Shares, representing approximately 1.35 per cent. of the Company's issued share capital.
Enquiries:
Polarean Imaging plc |
||||
Richard Hullihen, Chief Executive Officer |
Via Walbrook PR |
|||
Richard Morgan, Chairman |
|
|||
|
|
|||
SP Angel Corporate Finance LLP |
Tel: +44 (0)20 3470 0470 |
|||
David Hignell / Soltan Tagiev (Corporate Finance) |
|
|||
Vadim Alexandre / Rob Rees (Corporate Broking) |
|
|||
|
|
|||
Walbrook PR |
Tel: +44 (0)20 7933 8780 or polarean@walbrookpr.com |
|||
Anna Dunphy / Paul McManus |
Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893 |
|||
Market Abuse Regulation (MAR) Disclosure
Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:
1. |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
a) |
Name: |
Dr Jonathan Allis |
||||||
2. |
Reason for the notification |
|||||||
a) |
Position/status: |
Non-Executive Director |
||||||
b) |
Initial notification/Amendment: |
Initial notification |
||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
a) |
Name: |
Polarean Imaging Plc |
||||||
b) |
LEI: |
213800DGR2BHXJ36OL37 |
||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
a) |
Description of the financial instrument, type of instrument: Identification code:
|
Ordinary shares of £0.00037 GB00BF3DT583 |
||||||
b) |
Nature of the transaction: |
Purchase of shares |
||||||
c) |
Price(s) and volume(s): |
|
||||||
d) |
Aggregated information: Aggregated volume: Price: |
Single transaction as in 4 c) above
|
||||||
e) |
Date of the transaction: |
15.48hrs on 8 October 2019 |
||||||
f) |
Place of the transaction: |
Outside a trading venue |